Tool Calling and Plugins for Peptide Drug Clinical Trial

Data Characteristics in this Category

Data for peptide drug clinical trial pre-screening primarily comes from public clinical trial registries (e.g., ClinicalTrials.gov), patent databases, biological activity databases (e.g., ChEMBL, PubChem), and internal experimental data. Update frequencies vary: clinical trial registration information often updates in real-time or daily, patent data updates in batches, and biological activity data might update quarterly or annually. Document structures are diverse. Clinical trial protocols are typically PDF files, containing detailed trial designs, inclusion/exclusion criteria, dosing regimens, and endpoint indicators. Peptide sequence data is usually in FASTA format, and structural data is in PDB or SDF format. Fields and units are specific, for example, peptide sequence, molecular weight (Da), isoelectric point (pI), half-life (h), binding affinity (nM or μM), and clinical trial parameters like dose (mg/kg), dosing frequency, and adverse event grades (CTCAE v5.0).

Constraints Imposed by These Characteristics on Tool Calling and Plugins

The diversity and specificity of peptide drug data place specific requirements on tool calling and plugin configuration. First, dispersed data sources and varied formats demand that tool calls flexibly handle multiple data interfaces (APIs, database connections, file parsing). Second, analyzing complex fields like peptide sequences and structures requires specialized bioinformatics tool support, such as sequence alignment, structure prediction, and ADMET (absorption, distribution, metabolism, excretion, and toxicity) prediction plugins. Clinical trial data involves strict inclusion/exclusion criteria and dose adjustment logic, requiring plugins with complex conditional branching and rule engine capabilities. Furthermore, unique peptide properties (e.g., modification sites, cyclic structures) may lead to inaccurate parsing or processing by existing general tools, necessitating custom plugins or parameter fine-tuning of existing tools. Inconsistent data update frequencies also require tool calls to have caching strategies and version control capabilities to ensure the timeliness and traceability of pre-screening results.

Configuration Guidelines

Configuration Item	Recommended Value	Rationale
`maxContext`	`4096`	Peptide sequence and trial protocol text lengths vary significantly. This provides sufficient context space to process long texts and avoid truncating critical information.
`Recall count` (Recall Count)	`10–20`	Considers the number of relevant peptide drug literature and database entries. Increases recall to improve pre-screening coverage while ensuring relevance.
`Similarity threshold` (Similarity Threshold)	`0.75–0.85`	Peptide sequence or structural similarity judgment needs some tolerance while avoiding recalling too many irrelevant results. The specific value requires empirical calibration based on peptide type and pre-screening goals.
`PARSE_FILE_TIMEOUT_SECONDS`	`120 seconds` (120 seconds)	Complex file parsing, such as clinical trial protocol PDFs, is time-consuming. Extending the timeout ensures large files are processed completely and prevents parsing interruptions.
`API_KEY_ROTATION_INTERVAL`	`7 days` (7 days)	When accessing external biological database APIs (e.g., ChEMBL), regularly rotate API Keys to enhance security and address usage frequency limits imposed by some services.
`tool_schema_version`	`v1.2`	Ensures compatibility with the latest tool description protocol version supported by FastGPT, leveraging new features like richer parameter types and error handling mechanisms.

Three Common Mistakes

Symptom: API call returns 401 Unauthorized error code. Cause: The API Key for the external database or bioinformatics tool is incorrectly configured, expired, or lacks sufficient access permissions.
Symptom: In tool call results, a specific field of the peptide sequence (e.g., modification site) is empty or incorrectly formatted. Cause: Peptide data sources are diverse; some data sources have field naming or encoding methods inconsistent with the tool's expectations, leading to parsing failure or data loss.
Symptom: The workflow repeatedly executes after a specific plugin, leading to wasted resources or redundant results. Cause: The plugin execution logic lacks clear termination conditions or return states, causing the workflow to incorrectly assume further processing is needed, or a ToolCallStop node is not explicitly used after the tool call.

How to Confirm Correct Configuration

Manually execute tool calls for key peptide sequences or clinical trial IDs. Compare the output results with data from the original database to ensure correct field parsing and unit conversion.
Select a representative set of peptide drug cases. Simulate the complete pre-screening process, observing whether all tool calls and plugins execute in the expected order. Check intermediate outputs and final results.
Monitor tool call logs for frequent timeouts, error codes, or abnormal information. Ensure all external API calls return 200 OK or 20x Success status codes.
Verify that peptide characteristic data returned by plugins (e.g., molecular weight, pI, half-life) are within a reasonable range. Cross-reference with known literature data to confirm the accuracy of calculation logic.

The values provided are common starting points and should be measured against specific samples.

Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.